Evidence map›Paper›PMID 29861497›Full record

ArticleThe American journal of case reports2018

Ischemic Stroke Caused by Secondary Polycythemia and Incidentally-Found Renal Cell Carcinoma: A Case Report.

Andrew K Corse, Heather Kurtis

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andrew K CorseDepartment of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
Heather KurtisDepartment of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
University of Vermont · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Secondary polycythemia is a potential complication of an erythropoietin-secreting renal cell carcinoma. Increased red blood cell mass can elevate blood viscosity, which can impair blood flow, making individuals susceptible to vaso-occlusive events. One of the serious potential complications of a hyper-viscous state is ischemic stroke. CASE REPORT We present the case of a patient who was brought to the Emergency Department with right-sided extremity weakness and slurred speech consistent with acute ischemic stroke. MRI showed acute infarct involving the left corona radiata and posterior limb of the left internal capsule. On admission, he was found to have increased hemoglobin and hematocrit. An ultrasound of his abdomen found a heterogeneous mass of the right kidney, which was confirmed with CT scan. The patient remained in the hospital for 6 days. His hospital course was complicated by the incidental findings of polycythemia and a renal mass consistent with renal cell carcinoma. His hemoglobin and hematocrit remained elevated throughout his hospital course, and his erythropoietin level was found to be elevated as well. CONCLUSIONS High blood viscosity is associated with increased incidence of cardiovascular complications, including reduced cerebral blood flow. This case report suggests that polycythemia secondary to an erythropoietin-secreting renal cell carcinoma can lead to ischemic stroke. After surgery to remove the carcinoma, the secondary polycythemia may resolve.

Indexed as

Brain IschemiaCarcinoma, Renal CellHumansIncidental FindingsKidney NeoplasmsMaleMiddle AgedPolycythemiaStroke

Identifiers

PMID29861497
PMCPMC6016561
OpenAlexW2805281742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.